Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy

NCT05952206 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

2312

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Angiolite: Sirolimus-eluting stent
DEVICE: Xience: Everolimus-eluting stent
DRUG: 1-month DAPT
DRUG: 12-month DAPT (Standard of care)

Sponsor

iVascular S.L.U.